[
  {
    "question": "A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/\u03bcL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis?",
    "answer": "Based on the provided information, the most likely diagnosis is Primary CNS Lymphoma (PCNSL) in the context of HIV infection. \n\nThe presence of a solitary, weakly ring-enhancing lesion with well-defined borders, lymphocytic predominant pleocytosis in the cerebrospinal fluid, and positivity for Epstein-Barr virus (EBV) DNA are all consistent with this diagnosis. PCNSL is a type of non-Hodgkin lymphoma that is more common in immunocompromised individuals, such as those with HIV/AIDS. The patient's low CD4 count (90/\u03bcL) further supports this diagnosis.",
    "true_answer": "The most likely diagnosis for a patient with HIV, presenting with neurological symptoms and a solitary ring-enhancing lesion, is primary cerebral lymphoma."
  },
  {
    "question": "A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein?",
    "answer": "The medication that acts on the gp41 subunit of the HIV envelope glycoprotein is Enfuvirtide (T-20).",
    "true_answer": "The medication that targets the gp41 subunit of the HIV envelope glycoprotein is enfuvirtide."
  },
  {
    "question": "A 27-year-old man presents with a 2-week history of fever, malaise, and occasional diarrhea. On physical examination, the physician notes enlarged inguinal lymph nodes. An HIV-1 detection test is positive. Laboratory studies show a CD4+ count of 650/mm3. This patient is most likely currently in what stage of HIV infection?",
    "answer": "Based on the CD4+ count of 650/mm3, this patient is likely in the asymptomatic phase of HIV infection, also known as chronic HIV infection or clinical latency. This stage is characterized by the absence of symptoms and a relatively preserved immune system. It's worth noting that individuals in this stage may still be contagious and can transmit the virus to others.",
    "true_answer": "This patient is most likely currently in the stage of acute HIV infection."
  },
  {
    "question": "A 50-year-old male with HIV presents to his primary care provider complaining of persistent fevers and night sweats over the past four months. He has also experienced a productive cough. He has been poorly adherent to his HAART regimen. His past medical history also includes gout, hypertension, and diabetes mellitus. He takes allopurinol, enalapril, and metformin. His temperature is 100.9\u00b0F (38.3\u00b0C), blood pressure is 125/75 mmHg, pulse is 95/min, and respirations are 20/min. His CD4 count is 85 cell/mm^3 and a PPD is negative. A chest radiograph reveals cavitations in the left upper lobe and left lower lobe. Bronchoalveolar lavage reveals the presence of partially acid-fast gram-positive branching rods. A head CT is negative for any intracranial process. What is the mechanism of action of the most appropriate drug for managing this patient\u2019s condition?",
    "answer": "Based on the patient's presentation and lab results, the most likely diagnosis is Mycobacterium avium complex (MAC) infection, which is a common opportunistic infection in HIV patients with low CD4 counts.\n\nThe partially acid-fast gram-positive branching rods in the bronchoalveolar lavage support this diagnosis. \n\nThe most appropriate drug for managing MAC infection is a macrolide antibiotic, such as clarithromycin. The mechanism of action of clarithromycin is as a bacteriostatic agent that inhibits protein synthesis by binding to the 50S ribosomal subunit of bacteria, specifically targeting the 23S rRNA. This prevents the transpeptidation step in protein synthesis, ultimately leading to bacterial cell death.\n\nA combination of clarithromycin, ethambutol, and rifabutin is often used for the treatment of MAC infection in HIV patients.",
    "true_answer": "The mechanism of action of the most appropriate drug to manage this patient's condition is inhibition of bacterial folic acid synthesis."
  },
  {
    "question": "A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing?",
    "answer": "The HIV envelope proteins primarily targeted by the natural humoral immune response include gp120 and gp41. However, gp41 is the more likely target of the antibody being designed. \n\ngp41 is a transmembrane protein that plays a crucial role in the fusion of the HIV virus with the host cell membrane. It is a more conserved region of the HIV envelope, meaning its structure is less likely to mutate over time, making it a more stable target for an antibody.",
    "true_answer": "The most likely target of the antibody being designed for HIV envelope proteins is gp120."
  },
  {
    "question": "A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism?",
    "answer": "Based on the patient's presentation and biopsy findings, the most likely causal organism is Aspergillus. The septate hyphae that branch at acute angles are characteristic of Aspergillus species, which are common opportunistic pathogens in HIV-positive individuals, especially in those with compromised immune systems.",
    "true_answer": "The most likely causal organism for the symptoms presented is Aspergillus fumigatus."
  },
  {
    "question": "A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3\u20134 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?",
    "answer": "The addition of valganciclovir to the patient's current medication regimen puts him at greatest risk for renal impairment. Valganciclovir is a prodrug that is converted to ganciclovir in the body, which is primarily excreted through the kidneys. The combination of valganciclovir with other antiretroviral medications, particularly zidovudine (another nucleoside reverse transcriptase inhibitor), can increase the risk of renal impairment due to additive nephrotoxic effects.",
    "true_answer": "Treatment with valganciclovir places the patient at increased risk for pancytopenia."
  },
  {
    "question": "A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient\u2019s concern?",
    "answer": "For the newborn, the most appropriate diagnostic test for HIV would be the HIV DNA PCR (Polymerase Chain Reaction) test, also known as the viral load test. This test can detect the presence of the virus in the baby's blood and can provide results as early as 14-21 days after birth. This test is more sensitive than the antibody tests used in adults and can detect the virus even if the baby has not yet developed antibodies.",
    "true_answer": "The most appropriate test for early HIV diagnosis in a newborn is the polymerase chain reaction (PCR) for HIV RNA."
  },
  {
    "question": "A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?",
    "answer": "This is a complex situation, and confidentiality is a priority. However, as a healthcare provider, we also have a duty to protect the public health and the patient's partner. \n\nThe most appropriate next step is to inform the patient that, due to the risk of transmission to his wife, we are required by law to report the diagnosis to public health authorities. This is a standard procedure to ensure the wife can receive counseling and testing.",
    "true_answer": "The physician should report the HIV infection to the national health authorities while maintaining confidentiality per regulations."
  },
  {
    "question": "A 41-year-old woman presents with acute onset severe epigastric pain radiating to the back that began a few hours ago. She also complains of nausea and has vomited twice in the past hour. She denies any history of similar symptoms or trauma in the past. Past medical history is significant for diabetes type 2 and HIV infection diagnosed 6 months ago long-standing mild intermittent asthma, and generalized anxiety disorder. She takes metformin for her diabetes but does not remember the names of her HIV medications. She reports moderate social alcohol use. Her vital signs include temperature 37.6\u00b0C (99.6 \u00b0F), pulse 95/min, blood pressure 110/74 mm Hg, respiratory rate 12/min Her body mass index (BMI) is 21 kg/m2. Laboratory findings are significant for the following: Serum amylase: 415 U/L, Serum lipase: 520 U/L. A contrast CT of the abdomen reveals an edematous pancreas with peripancreatic fluid collection with a normal gallbladder. What is the most likely etiology of this patient\u2019s condition?",
    "answer": "Based on the patient's presentation, laboratory findings, and imaging results, the most likely etiology of this patient's condition is acute pancreatitis. The elevated serum amylase and lipase levels support this diagnosis. The patient's symptoms of epigastric pain radiating to the back, nausea, and vomiting also align with acute pancreatitis.\n\nGiven the patient's HIV status, it's essential to consider the possibility of an opportunistic infection, such as cytomegalovirus (CMV) pancreatitis, which is more common in immunocompromised patients. However, the normal gallbladder on CT and the absence of other risk factors for gallstones make this less likely.\n\nThe patient's history of moderate social alcohol use is also a potential contributing factor to acute pancreatitis. However, the acute onset of symptoms and the absence of a history of heavy alcohol use suggest that this may not be the primary cause.\n\nThe patient's diabetes and anxiety disorder are not directly related to the acute presentation of pancreatitis, but they may be relevant in the overall management and treatment of the patient.\n\nFurther investigation, including a detailed history of alcohol use, a CMV PCR, and potentially an endoscopic retrograde cholangiopancreatography (ERCP), may be necessary to determine the exact cause of the pancreatitis.",
    "true_answer": "It is most likely related to their HIV medication."
  },
  {
    "question": " A 28-year-old primigravid woman at 38 weeks' gestation is brought to the emergency department in active labor. She has not had regular prenatal care. She has a history of HIV infection but is not currently on antiretroviral therapy. Her previous viral load is unknown. Treatment with intravenous zidovudine is begun to reduce perinatal transmission of the virus. What biological process is most likely disrupted by this drug\u2019s action mechanism?",
    "answer": "The treatment with intravenous zidovudine in this case is aimed at reducing the transmission of HIV from mother to child. Zidovudine, also known as AZT, is a nucleoside reverse transcriptase inhibitor (NRTI).\n\nThe biological process most likely disrupted by zidovudine's action mechanism is the reverse transcription of the HIV viral RNA into DNA. Reverse transcription is the process by which the HIV virus converts its single-stranded RNA genome into a double-stranded DNA, which can then be integrated into the host cell's genome. Zidovudine inhibits this process by incorporating itself into the viral DNA and causing chain termination during the reverse transcription process, thereby preventing the replication of the virus.",
    "true_answer": " Zidovudine affects elongation of viral DNA by inhibiting the viral reverse transcriptase enzyme."
  },
  {
    "question": "What is known about DNA methylation profiles in patients with latent HIV-1 or with an active infection?",
    "answer": "DNA methylation is an epigenetic modification that plays a crucial role in regulating gene expression. In the context of HIV-1, studies have shown that DNA methylation profiles can differ between individuals with latent HIV-1 infection and those with active infection.\n\nResearch has found that latent HIV-1 infection is associated with global DNA hypomethylation (reduced methylation levels) in certain regions of the genome, particularly in areas near the HIV-1 promoter regions. This hypomethylation is thought to contribute to the reactivation of HIV-1 from latency.\n\nOn the other hand, active HIV-1 infection is associated with DNA hypermethylation (increased methylation levels) in certain regions of the genome, particularly in areas involved in immune response and inflammation.\n\nSpecifically, studies have identified distinct DNA methylation patterns in CD4+ T cells of individuals with latent HIV-1 infection, including:\n\n1. Hypomethylation of the HIV-1 long terminal repeat (LTR) region, which is the region that controls HIV-1 gene expression.\n2. Hypomethylation of genes involved in immune response, such as IFN-\u03b3 and TNF-\u03b1.\n3. Hypermethylation of genes involved in inflammation, such as IL-6 and IL-8.\n\nThese DNA methylation patterns can potentially serve as biomarkers for distinguishing between latent and active HIV-1 infection, and may also provide insights into the mechanisms underlying HIV-1 latency and reactivation.",
    "true_answer": "DNA methylation is correlated with and functionally linked to HIV-1 pathogenesis and latency. In active infection, HIV-1 infection is associated with global changes in host cell DNA methylation patterns, while in latent infection, methylation of the proviral DNA, particularly in the 5\u2019 LTR promoter and intragenic regions, plays a crucial role in maintaining viral latency."
  }
]